Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KVA

K V Pharma CL A (KVA)

K V Pharma CL A
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:KVA
DateTimeSourceHeadlineSymbolCompany
06/18/20129:04AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
06/18/20127:08AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
11/16/20118:15PMBusiness WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
11/02/20119:40PMBusiness WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/31/20119:30PMBusiness WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/28/20114:30PMBusiness WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/24/20111:52PMBusiness WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/20/20118:47PMBusiness WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/13/20119:02AMBusiness WireZeldes & Haeggquist, LLP Announces Investigation of K-V PharmaceuticalNYSE:KVAK V Pharma CL A
06/13/20118:00AMPR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVAK V Pharma CL A
04/01/20113:08PMDow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVAK V Pharma CL A
04/01/201110:28AMDow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVAK V Pharma CL A
03/31/20115:28PMDow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVAK V Pharma CL A
03/30/20113:58PMDow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
03/30/201112:38PMDow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
03/01/20118:49AMPR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVAK V Pharma CL A
02/14/201110:36AMPR Newswire (US)KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call CommentsNYSE:KVAK V Pharma CL A
02/14/201110:34AMPR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVAK V Pharma CL A
02/14/20119:48AMPR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVAK V Pharma CL A
02/04/20118:40AMPR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVAK V Pharma CL A
01/12/20119:03AMPR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestivaâ„¢NYSE:KVAK V Pharma CL A
09/14/201010:29AMDow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVAK V Pharma CL A
09/10/20109:53AMDow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVAK V Pharma CL A
02/25/20101:53PMPR Newswire (US)KV Pharmaceutical Reaches Agreement with U.S. Department of JusticeNYSE:KVAN^CURN
01/28/20105:04PMBusiness WireRobbins Umeda LLP Announces Investigation of KV Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
01/20/20103:41PMDow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVAK V Pharma CL A
01/20/20102:11PMDow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVAK V Pharma CL A
01/11/20109:18AMPR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVA
01/07/20104:10PMPR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVA
12/22/20095:34PMPR Newswire (US)KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010NYSE:KVA
 Showing the most relevant articles for your search:NYSE:KVA